RAD51C and triple-negative breast carcinoma: Among the 8 cases with RAD51C and RAD51D mutations, 6 (75%) were triple negative breast cancer, in agreement with the recent studies suggesting that mutations in these two genes may confer higher risks of triple-negative or basal subtypes of breast cancer [23, 24].